Tender For bid to ras corrigendum : supply of lignocaine intracam 0.05persent vial of 1 ml , ofloxacin 0.3persent bott of 5 ml , sodium chloride eye drops 5persent 5 ml bott , tobramycin 0.3persent bott of 5 ml , tropicamide 1persent with 5persent phenylephrine eye drops bott of 5 ml , proparacaine eye drops 0.5persent bott of 5 ml , syp diphenhydramine 10 15 mg per 5 ml and ammonium chloride 100 150 mg sodium citrate 50 85 mg per 5 ml bottle of 100 ml , fluticasone propionate 50 mcg bp nasal spray , betahistine dihydrochloride 8mg tab , cinnarizine 25 mg tab , prochlorperazine maleate 5mg tab , clotrimazole 1persent w per v ip plus lignocaine 2persent w per v ip ear drop bott of 10ml , chloramphenicol 5persent w per v clotrimazole 1persent w per v betamethasone 0.25 persent w per v lignocaine hcl 2persent w per v in bott of 5 ml ear drop , nasal decongestant adult drops xylometazoline hcl 0.1persent w per v nasal drop bottle of 10 ml , cefixime syp 50 mg per5ml bott of 30 ml , dicyclomine drops of 15 ml 1 ml equv 10 mg , metronidazole susp 200 mg per5ml bott of 60 ml , ondansetron syp 2 mg per5ml in bott of 30 ml , prednisolone syp 5mg per5ml in bott of 30 ml , syrup calcium phosphate 80 mg per5 ml 200 ml bottle , alprazolam 0.25 mg tab , doxepin hcl 75 mg cap , etophylline bp 84.7 mg and theophylline ip 25.3 mg per ml 2 ml inj , pirfenidone 200 mg tab , ipratropium bromide respirator soln 500 mcg per2 ml respule , cough syrupisto each 5 ml contains chlorpheniramine maleate ip 3 mg ammonium chloride ip 110 mg sodium citrate ip 46 mg menthol ip 0.9 mg bott of 110 ml , dextrose monohydrate for oral use in pack of 100 gm with or without vitamins and minerals , dextrose 50persent 100 ml inj , dextrose inj 25persent 100 ml inj , sodium bicarbonate 7.5persent amp of 10 ml , syp disodium hydrogen citrate 1.25 gm per5 ml bott of 100 ml , anti phlebitis cream tube of 15 g per 20 g , povidone iodine 10persent solution bott of 100 ml , calcium carbonate 500mg tab elemental vit d3 500 iu tab , vitamin b complex with a minimum concentration of vit b1 5mg vit b6 3mg and vit b12 5mcg therapeutic tab percap , calcium 9 mg plus calcium gluconate 50 mg inj for iv use 10 ml injection , vitamin d3 400 iu perml drops , budesonide 0.5 mg respules , fluticasone propionate cream 0.05persent tube of 10 gm , fexofenadine hydrochloride tab 120 mg , methyl prednisolone sodium acetate 80 mg inj , amoxycillin 500 mg plusclavulanic acid 125 mg tab , amoxycillin 250 mg plus clavulanic acid 50 mg 300 mg inj , ciprofloxacin 200 mg per100ml inj , clindamycin 300 mg cap , levofloxacin 500 mg in 100 ml inj , metronidazole inj for iv use containing 500 mg per bott of 100 ml , linezolid 2 mg perml 300 ml inj , nitrofurantoin 100 mg tab , inj nitroglycerine per glyceryltrinitrate 5 mg , syp zinc 20 mg per5 ml bottle of 100 ml , cabergoline 0.25 mg tab , misoprostol 600 mcg tab , typhoid polysaccharide tetanus toxoid conjugate vaccine 0.5ml , purified vero cell rabies vaccine , vitamin a oral dose 1 lakh iu per ml bott of 50 l , acid trichloroacetic , anti d rho immunoglobulin monoclonal human lyophilised freeze dried vial of 300 per350 mcg , tab misoprostol 25 mcg , inj drotavarine 20mg perml , ursodeoxycholic acid 300 mg tab , metoclopramide 10 mg tab , tab drotaverine 80 mg , multivitamin drops with constituents having vit a vit b1 b2 b6 vit c vit d bottle of 15ml osages as per recommended daily allowances , paraffin 15 ml containing magnesium hydroxide 11.25 ml and liq paraffin 3.75ml bott of 170ml , suppositories paracetamol 250 mg , tab tranexamic acid //bid details 2 / 96 500 mg plus mefenamic acid 250 mg , nor ethisterone 5mg tab , clingen pessary clindamycin plus clotrimazole , natural micronised progesterone 200 mg tab , fas kit combi kit of fluconazole 150 mg azithromycin 100 mg and secnidazole 1000 mg , inj multivitamin 10 ml iv , syp ofloxacin 50 mg plus metronidazole 120 mg bott of 30 ml , syp montelukast 4 mg plus levocetrizine 2.5 mg bott of 60 ml , syp dextrom
Tender For e-tender for procurement of drug items under table-a, for two years from the date of aoc. - amoxicillin trihydrate dispersible tabs. i.p 125mg, amoxycillin 250 mg + cloxacillin 250mg capsule., atropine sulphate inj. i.p. 0.6 mg/ml-1ml amp., azacitidine inj 100 mg /vial, azathioprine 50 mg tab., benzyl benzoate application i.p 25% w/w-500 ml bot., bimatoprost eye drop 0.03%, bupivacaine 0.5% inj - 20ml vial, cabergoline tab 0.5mg, caffeine citrate 1 ml inj per vial/amp, carmustine inj. 100mg/vial, cefotaxime sodium inj. i.p. 125 mg.vial., ceftazidime inj. 1gm./vial, cetuximab inj. 100mg( 5mg/ml) / - 20ml vial, cetuximab inj. 500 mg (5mg/ml)/100ml vial, cilostazol tab ip 50 mg, clopidogrel 75mg tab., daclatasvir 60 mg tab., decitabine inj 50 mg, deferasirox 250mg dispersable tab., desflurence inhalation agent 240 ml, dexamethasone 4 mg tab., dexamethasone tab. i.p. 0.5 mg, diclofenac sod. 50 mg tab., diclofenac sodium injection i.p. 25mg/ml- 3ml amps, digoxin tablet i.p. 0.25 mg, dorzolamide hydrochloride 2.0% eye drop in 5ml, fexofenadine tab 120 mg, fibrin sealent with fast & slow setting of thrombin 1ml, fludarabine inj. - 50mg / 5ml, flurourocil inj. i.p. 250mg. in 5ml. amp., fluticasone nasal spray ip 50 mcg (in maximum of 120 mdi pack), furosemide inj. i.p 20mg/2ml. ampoule, halazone tablet for solution u.s.p. 4mg, human hepatitis b immunoglobulin inj. 200 iu volume in 0.5 ml or 1 ml vial/pfs, ibrutinib 140 mg cap., infliximab inj. 100mg/vial, isosorbide-5-mononitrate 20 mg, isosorbide-dinitrate tab i.p. 5mg., ivermectin 6mg tab., leuprolide depot inj. 22.5 mg/vial, levetiracetam inj. 100 mg /ml in 5ml amps, levofloxacin 500 mg tab., levosalbutamol 1.25 mg + ipratropium bromide 500mcg respules, levosalbutamol oral suspension 1mg/5ml, linezolid infusion 600 mg / 300ml, linezolid syrup 100mg / 5ml, melphalan hcl inj. 50 mg (powder), methotrexate tab 15 mg, naproxen 250mg tab., neostigmine methylsulphate inj.i.p. 0.5mg/ ml - 1ml ampoule, nicorandil tabs 5mg, ondansetron inj. 2mg/ ml in 2ml amp., penicillamine 250 mg. cap., plerixafor inj 24mg/1.2ml per vial, polymixin b sulfate inj. 5,00,000 units/vial, pomalidomide 2mg tab / cap, prednisolone tab.20mg., pyrazinamide tab. i.p. 500mg, pyridostigmine tab 30 mg, risperidone tab. 2 mg, sacubitril + valsartan tab. 50mg, sodium chloride inj 0.45% in polypropelene bottle in ffs technology, sodium fusidate cream / ointment 2%, solifenacin 5mg tab., succinylated polygelline, sulfasalazine tab 500 mg, teicoplanin inj. 200 mg /vial, tetanus toxoid inj. (absorbed) 0.5ml amp. single dose, thiamine 100 mg. inj. per 2ml ampule, tinidazole tab ip 500 mg, tropicamide 0.8% with phenylephrine hydrochloride 5% eye drop, valethamate bromide inj 8 mg/ml in 1ml amp., vecuronium bromide inj. 2mg /ml 2ml vial, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f